Panel Discussion | Radiation Protection - Call for Action

Saturday, March 8, 2025

4:09 PM – 4:25 PM ET

Panel Moderator(s)

James A. Goldstein, MD, FSCAI

Director, Research and Education
Beaumont Health System
Royal Oak, Michigan, United States

Disclosure(s): ECLS Inc Licensee of Radiation Protection technology to Image Diagnostics Inc Fitchberg Mass: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-privately held company (Ongoing)
James B. Hermiller, MD, FACC, MSCAI

Director Interventional Cardiology
St. Vincent Medical Group
Indianapolis, Indiana, United States

Disclosure(s): Abbott Vascular, Edwards: Consultant (Ongoing)
David G. Rizik, MD, MSCAI, FACC

Chief Scientific Officer, Chief of Complex Interventional Cardiology, Director of Structural & Coronary Intervention, Interventional Cardiology Fellowship Program Director
HonorHealth, Scottsdale Arizona
Scottsdale, Arizona, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Megan Coylewright, MD, MPH

Editor
American College of Cardiology CardioSmart, Tennessee, United States

Disclosure(s): Alleviant Medical: Consultant (Ongoing); Boston Scientifiic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Edward Lifesciences: Consultant (Ongoing); Medtronic: Consultant (Ongoing)
Dean J. Kereiakes, MD, FACC, MSCAI

Chairman, The Christ Hospital Heart and Vascular Institute; Medical Director, The Christ Hospital Research Institute; Professor of Clinical Medicine, The Ohio State University
The Christ Hospital Health Network
Cincinnati, Ohio, United States

Disclosure(s): Ablative Solutions, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Elixir Medical Corporation: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); JC Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Orchestra Biomed: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Sino Medical Sciences Technology, Inc.: Consultant (Ongoing)
Morton J. Kern, MD, MSCAI, FACC, FAHA

Interventional Cardiologist
VA Long Beach Health Care System
Long Beach, California, United States

Disclosure(s): hemonetics-Opsens: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronics-Cathworks: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips; Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zoll- Therox: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
AK

Ajar Kochar, MD, MHS

Program Director
Brigham and Women's Hospital/Harvard Medical School
CHESTNUT HILL, Massachusetts, United States

Disclosure(s): Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); American Heart Association: Grant/Research Support (Ongoing); Faraday Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); Rampart Medical: Grant/Research Support (Ongoing); Shockwave Inc: Grant/Research Support (Ongoing)
Ryan D. Madder, MD

Section Chief of Interventional Cardiology & Director of Cardiac Cath Lab
Corewell Health
Ada, Michigan, United States

Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Angiowave Imaging: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Corindus: Grant/Research Support (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Gentuity: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Microbot Medical: Grant/Research Support (Ongoing); Nanoflex Robotics: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); RapidAI: Consulting Fees (e.g., advisory boards) (Ongoing); Spectrawave: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)
Kenneth Rosenfield, MD, MHCDS

section head, vascular medicine and intervention
Massachusetts General Hospital
boston, Massachusetts, United States

Disclosure information not submitted.
Eric A. Secemsky, MD, MSc

Director of Vascular Intervention
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

Disclosure(s): Abbott, BD, Boston Scientific, Cook, Cordis, Endovascular Engineering, Gore, InfraRedx, Medtronic, Philips, RapidAI, Rampart, Shockwave, Siemens, Teleflex, Terumo, Thrombolex, VentureMed, Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Disclosure(s):

James A. Goldstein, MD, FSCAI: ECLS Inc Licensee of Radiation Protection technology to Image Diagnostics Inc Fitchberg Mass: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-privately held company (Ongoing)

James B. Hermiller, MD, FACC, MSCAI: Abbott Vascular, Edwards: Consultant (Ongoing)

David G. Rizik, MD, MSCAI, FACC: No financial relationships to disclose

Megan Coylewright, MD, MPH: Alleviant Medical: Consultant (Ongoing); Boston Scientifiic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Edward Lifesciences: Consultant (Ongoing); Medtronic: Consultant (Ongoing)

Dean J. Kereiakes, MD, FACC, MSCAI: Ablative Solutions, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Elixir Medical Corporation: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); JC Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Orchestra Biomed: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Sino Medical Sciences Technology, Inc.: Consultant (Ongoing)

Morton J. Kern, MD, MSCAI, FACC, FAHA: hemonetics-Opsens: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronics-Cathworks: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips; Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zoll- Therox: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Ajar Kochar, MD, MHS: Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); American Heart Association: Grant/Research Support (Ongoing); Faraday Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); Rampart Medical: Grant/Research Support (Ongoing); Shockwave Inc: Grant/Research Support (Ongoing)

Ryan D. Madder, MD: Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Angiowave Imaging: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Corindus: Grant/Research Support (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Gentuity: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Microbot Medical: Grant/Research Support (Ongoing); Nanoflex Robotics: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); RapidAI: Consulting Fees (e.g., advisory boards) (Ongoing); Spectrawave: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

Eric A. Secemsky, MD, MSc: Abbott, BD, Boston Scientific, Cook, Cordis, Endovascular Engineering, Gore, InfraRedx, Medtronic, Philips, RapidAI, Rampart, Shockwave, Siemens, Teleflex, Terumo, Thrombolex, VentureMed, Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)